Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Nutshell Therapeutics Shanghai Co LTD received IND clearance from the FDA to initiate Phase clinical trial in the United States for its NTS a novel small molecule allosteric reactivator targeting p YC mutation
Novo Nordisk announced that the US Food and Drug Administration FDA accepted its New Drug Application NDA submission for an investigational oncedaily mg oral formulation of Wegovy semaglutide
BGM Group Ltd a leading AI technology company today announced it has entered into a definitive agreement the Agreement to acquire HM Management Company Limited HM Management a prominent AI agent production platform
Crown Bioscience a global contract research organization CRO headquartered in the United States and part of JSR Life Sciences and Japanbased JSR Corporation is pleased to announce the extension of its partnership with NEXT Oncology
Genmab AS announced today its intention to submit in the first half of a supplemental Biologics License Application sBLA to the US Food and Drug Administration FDA for subcutaneous epcoritamab a bispecific antibody being investigated
InnoCare Pharma a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases announced today that its new generation panTRK inhibitor zurletrectinib ICP has been granted priority review
Rein Therapeuticsa biopharmaceutical company advancing a novel pipeline of firstinclass medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications and Qureight Ltd a Core
Symbiosis is delighted to announce the successful completion of the latest audit by the UKs Medicines and Healthcare products Regulatory Agency MHRA following an inspection of our new GMP manufacturing facility
Aptamer Group plc the leading developer of nextgeneration synthetic binders delivering innovation to the life science industry has entered into a global licensing agreement with the University of Glasgow for the commercial use of a developed panel of...
Satsuma Pharmaceuticals Inc a latestage biopharmaceutical company dedicated to bringing novel treatments to people who suffer from migraine and other debilitating conditions and its corporate parent Shin Nippon Biomedical Laboratories
